Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03488953	TitleTrasplante hepático de donante vivo con hepatectomía en dos fases para pacientes con metástasis hepáticas colorrectales aisladas e irresecables	Fase No aplicable	Date Added 2018-04-05	Ubicación Alemania	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03476681	TitleStudy of NEO-201 in Solid Tumors Expansion Cohorts	Fase Phase 1, Phase 2	Date Added 2018-03-26	Ubicación Maryland, United States Virginia, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas NEO-201 in combination with pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03475004	TitleStudy of Pembrolizumab, Binimetinib, and Bevacizumab in Patients With Refractory Colorectal Cancer	Fase Fase 2	Date Added 2018-03-23	Ubicación Colorado, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas Pembrolizumab, Bevacizumab, and Binimetinib	Etiquetas MSS/ MMRp
NCT ID NCT03412877	TitleAdministración de células T autólogas modificadas genéticamente para expresar receptores de células T reactivos contra neoantígenos en personas con cáncer metastásico	Fase Fase 2	Date Added 2018-01-29	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas Aldesleukin, Cyclophosphamide, Fludarabine, Individual Patient TCR-Transduced PBL, Pembrolizumab (Keytruda)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03400332	TitleEstudio de BMS-986253 en combinación con nivolumab o nivolumab más ipilimumab en cánceres avanzados.	Fase Fase 2	Date Added 2018-01-17	Ubicación Arkansas, United States California, United States Colorado, United States Georgia, United States Maryland, United States Massachusetts, United States Michigan, United States Nebraska, United States Nevada, United States New Jersey, United States New York, United States Oklahoma, United States Oregon, United States Pennsylvania, United States South Carolina, United States Texas, United States Utah, United States Virginia, United States Australia Bélgica Canadá Francia Alemania Italia Polonia España Suecia Suiza Reino Unido	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas BMS-986253, Ipilimumab, Nivolumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03388632	TitleInterleucina-15 recombinante en combinación con los inhibidores de puntos de control nivolumab e ipilimumab en pacientes con cáncer refractario	Fase Fase 1	Date Added 2018-01-03	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed No	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, rhIL-15, Opdivo, Yervoy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03388190	TitleMETIMMOX: Colorectal Cancer METastasis – Shaping Anti-tumor IMMunity by OXaliplatin	Fase Fase 2	Date Added 2018-01-02	Ubicación Noruega	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas FLOX, Nivolumab, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT03368963	TitleTAS102 in Combination With NAL-IRI in Advanced GI Cancers	Fase Phase 1, Phase 2	Date Added 2017-12-11	Ubicación Georgia, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Nanoliposomal Irinotecan, Trifluridine and Tipiracil Hydrochloride	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03366155	TitleHepatic Artery Infusion Pump Chemotherapy With Floxuridine and Dexamethasone in Combination With Systemic Chemotherapy for Patients With Colorectal Cancer Metastatic to the Liver	Fase Fase 2	Date Added 2017-12-08	Ubicación Maryland, United States	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas 5FU, cetuximab, FUDR-Dex, Irinotecan, Medtronic SynchroMed II Pump with Codman 3000 Constant Flow Pump Catheter, OneRNA, oxaliplatin, panitumumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03365882	TitleS1613, Trastuzumab and Pertuzumab or Cetuximab and Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic HER2/Neu Amplified Colorectal Cancer That Cannot Be Removed by Surgery	Fase Fase 2	Date Added 2017-12-07	Ubicación Alaska, United States Arizona, United States Arkansas, United States California, United States Colorado, United States Connecticut, United States Florida, United States Georgia, United States Hawaii, United States Idaho, United States Illinois, United States Indiana, United States Iowa, United States Kansas, United States Kentucky, United States Louisiana, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States Mississippi, United States Missouri, United States Montana, United States Nebraska, United States Nevada, United States New Hampshire, United States New Jersey, United States New Mexico, United States North Carolina, United States North Dakota, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States Rhode Island, United States South Carolina, United States Tennessee, United States Texas, United States Utah, United States Vermont, United States Washington, United States West Virginia, United States Wisconsin, United States Wyoming, United States Puerto Rico	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas cetuximab, HER-2 testing, Irinotecan Hydrochloride, Pertuzumab, Trastuzumab, Camptosar, Erbitux, Herceptin, Perjeta	Etiquetas MSS/ MMRp

Showing 241 to 250 of 299 entries